Assessing cancer drug combination efficacy across 900+PRISM cell lines in a multiplexed screening assay

被引：0
|
作者：
George, Ashish Bino
Nair, Shiker
Kocak, Mustafa
Nguyen, Ellen
Kalathungal, Alvin
Fazio, Anthony
Ponsi, Cole
Golabi, Aydin
Ronan, Melissa A.
Rees, Matthew G.
Roth, Jennifer A.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4560
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Screening of NXP900 and dasatinib across 121 cancer cell lines identifies differences in their antiproliferative activity profiles
    King, B.
    Hughes, R. E.
    Navarro-Marchal, S.
    Brunton, V. G.
    Poradosu, E.
    Carragher, N. O.
    Unciti-Broceta, A.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S113 - S113
  • [2] Evaluating drug efficacy in bladder cancer cell lines
    Pinto-Leite, R.
    Santos, L.
    Oliveira, P. A.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S5 - S5
  • [3] Developing 384-well and 1536-well cell growth inhibition assay workflow for screening drug-drug combination in tumor cell lines
    Li, Yvonne
    Ma, Mike
    Chan, Julie
    Tian, Yang
    Pagratis, Nikos
    Stonich, Derek
    Chen, Victor
    Zhang, Louis
    Kenney, Mark
    CANCER RESEARCH, 2016, 76
  • [4] Examination of anticancer drug screening by human cancer cell lines
    Matsui, Megumi
    Kakita, Misato
    Ijiri, Sumiko
    Moriyasu, Matsuko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 245P - 245P
  • [5] Screening for drug activity in resistant cancer cell lines.
    Rickardson, L
    Haglund, C
    Fryknäs, M
    Lövborg, H
    Nygren, P
    Gustafsson, MG
    Isaksson, A
    Larsson, R
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8987S - 8987S
  • [6] Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions
    Schmidt, Linnea
    Kling, Teresia
    Monsefi, Naser
    Olsson, Maja
    Hansson, Caroline
    Baskaran, Sathishkumar
    Lundgren, Bo
    Martens, Ulf
    Haggblad, Maria
    Westermark, Bengt
    Nilsson, Karin Forsberg
    Uhrbom, Lene
    Karlsson-Lindahl, Linda
    Gerlee, Philip
    Nelander, Sven
    NEURO-ONCOLOGY, 2013, 15 (11) : 1469 - 1478
  • [7] A Novel PAA Derivative with Enhanced Drug Efficacy in Pancreatic Cancer Cell Lines
    Alsuraifi, Ali
    Lin, Paul Kong Thoo
    Curtis, Anthony
    Lamprou, Dimitrios A.
    Hoskins, Clare
    PHARMACEUTICALS, 2018, 11 (04)
  • [8] Immune checkpoint reporter cell lines based on the protein profiling of ATCC cell lines for cancer immunotherapy drug screening
    Chang, Hyeyoun
    Tyo, Kevin
    Foulke, John
    Chen, Luping
    Gu, Zhizhan
    Tian, Fang
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Increased reversal of drug resistance with low dose combination of modulators in drug resistant cancer cell lines
    Mubashar, M
    Chaudhary, KS
    Lalani, EN
    Stamp, GW
    Peters, AM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 988 - 988
  • [10] DIFFERENTIAL PATHWAY DEPENDENCY DISCOVERY ASSOCIATED WITH DRUG RESPONSE ACROSS CANCER CELL LINES
    Speyer, Gil
    Mahendra, Divya
    Tran, Hai J.
    Kiefer, Jeff
    Schreiber, Stuart L.
    Clemons, Paul A.
    Dhruv, Harshil
    Berens, Michael
    Kim, Seungchan
    PACIFIC SYMPOSIUM ON BIOCOMPUTING 2017, 2017, : 497 - 508
12345